Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Shanghai - Delayed Quote CNY

Cathay Biotech Inc. (688065.SS)

Compare
48.99
+0.08
+(0.16%)
At close: March 14 at 3:00:02 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,763,768.21
2,114,174.87
2,441,103.97
2,363,482.65
1,497,191.40
Cost of Revenue
1,887,591.37
1,505,424.70
1,580,841.11
1,521,387.53
799,158.81
Gross Profit
876,176.83
608,750.17
860,262.86
842,095.11
698,032.59
Operating Expense
443,351.78
335,405.41
407,208.73
306,694.78
202,922.57
Operating Income
432,825.06
273,344.75
453,054.12
535,400.34
495,110.02
Net Non Operating Interest Income Expense
44,892.49
181,898.25
212,151.12
196,421.50
29,192.30
Pretax Income
443,979.88
448,924.54
695,991.91
724,448.69
520,787.75
Tax Provision
50,354.49
40,388.95
83,337.05
90,937.17
63,446.76
Net Income Common Stockholders
397,816.59
366,524.35
553,265.97
594,719.10
457,672.11
Basic EPS
0.68
0.63
0.95
1.02
0.84
Diluted EPS
0.68
0.63
0.95
1.02
0.84
Basic Average Shares
584,617.90
581,784.69
582,385.24
583,057.94
543,000.81
Diluted Average Shares
584,617.90
581,784.69
582,385.24
583,057.94
543,000.81
Total Operating Income as Reported
444,850.31
454,295.17
708,283.80
723,350.46
522,232.36
Total Expenses
2,330,943.15
1,840,830.12
1,988,049.85
1,828,082.31
1,002,081.39
Net Income from Continuing & Discontinued Operation
397,816.59
366,524.35
553,265.97
594,719.10
457,672.11
Normalized Income
447,106.65
387,202.15
585,116.76
604,021.52
459,971.34
Interest Income
165,302.39
219,770.69
236,775.92
213,307.91
33,365.62
Interest Expense
31,321.92
32,171.79
20,009.95
16,291.97
3,857.23
Net Interest Income
44,892.49
181,898.25
212,151.12
196,421.50
29,192.30
EBIT
475,301.79
481,096.33
716,001.86
740,740.66
524,644.98
EBITDA
475,301.79
766,811.69
981,123.80
909,275.99
642,962.41
Reconciled Cost of Revenue
1,887,591.37
1,505,424.70
1,580,841.11
1,521,387.53
799,158.81
Reconciled Depreciation
--
285,715.36
265,121.93
168,535.33
118,317.43
Net Income from Continuing Operation Net Minority Interest
397,816.59
366,524.35
553,265.97
594,719.10
457,672.11
Total Unusual Items Excluding Goodwill
-55,595.49
-22,722.06
-36,183.33
-10,637.73
-2,618.21
Total Unusual Items
-55,595.49
-22,722.06
-36,183.33
-10,637.73
-2,618.21
Normalized EBITDA
530,897.29
789,533.75
1,017,307.12
919,913.72
645,580.62
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-6,305.43
-2,044.26
-4,332.54
-1,335.31
-318.97
12/31/2020 - 8/12/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

N13.BE NanoXplore Inc
1.5540
+1.83%
 
39EA.F Ganfeng Lithium Group Co., Ltd.
2.6400
+2.40%
 
AHKSY Asahi Kasei Corporation
14.11
+0.21%
 
PETKM.IS Petkim Petrokimya Holding Anonim Sirketi
18.28
+0.11%
 
DESN.SW Dottikon ES Holding AG
194.80
+1.78%
 
SHECY Shin-Etsu Chemical Co., Ltd.
15.06
-0.07%
 
2350.SR Saudi Kayan Petrochemical Company
5.95
+0.34%
 
BAS.DU Basf SE
52.75
+2.93%
 
VHI Valhi, Inc.
18.19
+4.96%
 
GPRE Green Plains Inc.
5.16
+1.57%